Amrize (NYSE:AMRZ) Hits New 12-Month Low - Should You Sell?

Key Points

• Amrize shares fell to a new 52-week low of $41.52, trading below both their 50-day and 200-day moving averages. The stock has declined after the company reported quarterly EPS of $0.88, below the $0.92 consensus estimate.
• Analyst sentiment is mixed but leans cautious: Amrize has an average “Hold” rating and a $55.50 consensus price target, while Bank of America cut its target to $40 and maintained an “Underperform” rating.
• Despite the weakness, insiders purchased nearly 49,000 shares worth about $2.16 million over the past 90 days, and the company paid a quarterly dividend of $0.11 per share.

Amrize Ltd (NYSE:AMRZ - Get Free Report)'s share price hit a new 52-week low on Wednesday . The company traded as low as $41.52 and last traded at $41.8840, with a volume of 320083 shares traded. The stock had previously closed at $41.95.

Analysts Set New Price Targets

A number of brokerages recently issued reports on AMRZ. Bank of America reissued an "underperform" rating and issued a $40.00 price objective (down from $50.00) on shares of Amrize in a research note on Wednesday, September 2nd. Weiss Ratings downgraded Amrize from a "hold (c)" rating to a "hold (c-)" rating in a report on Monday, August 31st. Morgan Stanley set a $63.00 price target on Amrize and gave the company an "overweight" rating in a research note on Monday, June 22nd. Oppenheimer decreased their target price on Amrize from $68.00 to $65.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 21st. Finally, Truist Financial reiterated a "hold" rating and set a $48.00 price target (down from $65.00) on shares of Amrize in a report on Tuesday, July 7th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eight have given a Hold rating and four have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $55.50.

Amrize Trading Down 1.5%

The firm's 50-day moving average is $47.99 and its 200 day moving average is $52.95. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $22.85 billion, a price-to-earnings ratio of 19.03, a P/E/G ratio of 1.23 and a beta of 0.04.

Amrize (NYSE:AMRZ - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The business had revenue of $3.49 billion during the quarter. On average, equities analysts predict that Amrize Ltd will post 2.72 earnings per share for the current fiscal year.

Amrize Announces Dividend

The business also recently announced a dividend, which was paid on Wednesday, August 26th. Investors of record on Tuesday, August 18th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, August 18th. Amrize's payout ratio is presently 20.28%.

Insider Buying and Selling

In other news, Director Jacques Sanche bought 4,150 shares of the firm's stock in a transaction that occurred on Wednesday, August 26th. The stock was acquired at an average cost of $45.02 per share, with a total value of $186,833.00. Following the transaction, the director directly owned 9,766 shares of the company's stock, valued at approximately $439,665.32. This represents a 73.90% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Baris Oran purchased 3,000 shares of the business's stock in a transaction on Tuesday, August 11th. The stock was purchased at an average price of $47.38 per share, for a total transaction of $142,140.00. Following the acquisition, the chief financial officer owned 3,000 shares of the company's stock, valued at approximately $142,140. This represents a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders acquired a total of 48,983 shares of company stock worth $2,158,755 over the last 90 days. 0.54% of the stock is owned by company insiders.

Hedge Funds Weigh In On Amrize

A number of large investors have recently modified their holdings of the company. California State Teachers Retirement System boosted its holdings in Amrize by 5,444.5% during the second quarter. California State Teachers Retirement System now owns 30,472,836 shares of the company's stock worth $1,624,202,000 after purchasing an additional 29,923,230 shares during the last quarter. Norges Bank bought a new position in shares of Amrize during the 4th quarter worth approximately $929,333,000. Harris Associates L P bought a new position in shares of Amrize during the 4th quarter worth approximately $615,406,000. Wellington Management Group LLP boosted its stake in shares of Amrize by 48.8% in the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company's stock worth $561,018,000 after buying an additional 3,809,133 shares during the last quarter. Finally, Marshall Wace LLP boosted its stake in shares of Amrize by 865.4% in the 3rd quarter. Marshall Wace LLP now owns 2,889,660 shares of the company's stock worth $139,436,000 after buying an additional 2,590,336 shares during the last quarter.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.